Protocol for differentiation of monocytes and macrophages from human induced pluripotent stem cells

Kevin Emmerich1, Francesca Calcaterra2, Xuming Tang1

  • 1Translational Vascular Medicine Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20814, USA.

STAR Protocols
|July 28, 2024
PubMed

Insights

This study presents a protocol for generating monocytes and macrophages from human induced pluripotent stem cells (hiPSCs). This method overcomes limitations in studying these immune cells due to primary tissue scarcity.

Area of Science:

  • Immunology
  • Stem Cell Biology
  • Cellular Differentiation

Background:

  • Studying monocytes and macrophages is crucial for understanding various diseases.
  • Primary tissue availability limits research on these vital immune cells.
  • Human induced pluripotent stem cell (hiPSC) technology offers a potential solution.

Purpose of the Study:

  • To establish a detailed protocol for differentiating monocytes and macrophages from hiPSCs.
  • To provide a reliable method for generating disease-relevant immune cells in vitro.

Main Methods:

  • hiPSC maintenance and culture.
  • Induction of mesoderm and hematopoietic progenitor cells (HPCs).
  • Myeloid lineage induction, monocyte formation, and macrophage differentiation.
  • Functional characterization and polarization of derived macrophages.

Main Results:

  • Successful differentiation of monocytes and macrophages from hiPSCs.
  • Detailed procedural steps for each stage of differentiation.
  • Demonstration of functional macrophage capabilities, including polarization.

Conclusions:

  • The presented protocol enables the generation of monocytes and macrophages from hiPSCs.
  • This method provides a valuable tool for immunological research and disease modeling.
  • Overcomes limitations associated with primary tissue scarcity in immune cell studies.

Related Concept Videos